IMUGENE HAS ADVISED AROVELLA THAT IT NO LONGER WISHES TO CONTINUE COLLABORATION
Why? Because we love what we are seeing in our current trials and expect to be making a major announcement in the near future ... and therefore have no need of further collaboration. Sorry Arovella.
Imagine what the share price would do if IMU announced the above as being the reason for the termination ... and it is entirely possible it is the real reason.
News: IMU Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update, page-2
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $175.3K | 3.606M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 71 | 7947713 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2347789 | 25 |
View Market Depth
| Last trade - 13.52pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |